Bartlett & Co’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | $984K | Sell |
11,800
-937
| -7% | -$71.4K | 0.02% | 276 |
|
|
2023
Q3 | $1.01M | Sell |
12,737
-59
| -0.5% | -$4.94K | 0.02% | 261 |
|
|
2023
Q2 | $1.14M | Buy |
12,796
+2,015
| +19% | +$173K | 0.02% | 258 |
|
|
2023
Q1 | $878K | Sell |
10,781
-2,403
| -18% | -$196K | 0.02% | 237 |
|
|
2022
Q4 | $1.03M | Sell |
13,184
-5,599
| -30% | -$454K | 0.02% | 228 |
|
|
2022
Q3 | $1.53M | Sell |
18,783
-75
| -0.4% | -$6.74K | 0.03% | 190 |
|
|
2022
Q2 | $1.71M | Sell |
18,858
-7,569
| -29% | -$767K | 0.03% | 178 |
|
|
2022
Q1 | $2.95M | Sell |
26,427
-2,613
| -9% | -$276K | 0.05% | 157 |
|
|
2021
Q4 | $3.02M | Sell |
29,040
-819
| -3% | -$94.8K | 0.05% | 161 |
|
|
2021
Q3 | $3.74M | Buy |
29,859
+688
| +2% | +$89K | 0.07% | 137 |
|
|
2021
Q2 | $3.62M | Sell |
29,171
-1,092
| -4% | -$137K | 0.07% | 139 |
|
|
2021
Q1 | $3.58M | Buy |
30,263
+717
| +2% | +$84K | 0.07% | 139 |
|
|
2020
Q4 | $3.46M | Sell |
29,546
-338
| -1% | -$37.2K | 0.07% | 143 |
|
|
2020
Q3 | $3.11M | Sell |
29,884
-2,906
| -9% | -$292K | 0.07% | 139 |
|
|
2020
Q2 | $3.01M | Sell |
32,790
-1,294
| -4% | -$124K | 0.08% | 140 |
|
|
2020
Q1 | $3.07M | Buy |
+34,084
| New | +$3.63M | 0.09% | 135 |
|
|
2019
Q3 | $4M | Buy |
36,866
+34,693
| +1,597% | +$3.62M | 0.11% | 129 |
|
|
2019
Q2 | $212K | Buy |
2,173
+7
| +0.3% | +$639 | 0.01% | 252 |
|
|
2019
Q1 | $197K | Sell |
2,166
-461
| -18% | -$41.3K | 0.01% | 255 |
|
|
2018
Q4 | $239K | Hold |
2,627
| – | – | 0.01% | 238 |
|
|
2018
Q3 | $258K | Sell |
2,627
-80
| -3% | -$7.4K | 0.01% | 239 |
|
|
2018
Q2 | $232K | Buy |
2,707
+870
| +47% | +$72.7K | 0.01% | 239 |
|
|
2018
Q1 | $147K | Buy |
1,837
+487
| +36% | +$40.2K | 0.01% | 282 |
|
|
2017
Q4 | $109K | Sell |
1,350
-410
| -23% | -$32.8K | ﹤0.01% | 314 |
|
|
2017
Q3 | $137K | Sell |
1,760
-150
| -8% | -$12.5K | 0.01% | 289 |
|
|
2017
Q2 | $170K | Hold |
1,910
| – | – | 0.01% | 267 |
|
|
2017
Q1 | $154K | Sell |
1,910
-43
| -2% | -$3.36K | 0.01% | 273 |
|
|
2016
Q4 | $139K | Sell |
1,953
-2,000
| -51% | -$157K | 0.01% | 282 |
|
|
2016
Q3 | $342K | Sell |
3,953
-923
| -19% | -$80.4K | 0.02% | 211 |
|
|
2016
Q2 | $423K | Sell |
4,876
-1,022
| -17% | -$82.6K | 0.02% | 200 |
|
|
2016
Q1 | $442K | Sell |
5,898
-1,961
| -25% | -$148K | 0.02% | 194 |
|
|
2015
Q4 | $605K | Hold |
7,859
| – | – | 0.03% | 177 |
|
|
2015
Q3 | $526K | Sell |
7,859
-250
| -3% | -$18.4K | 0.03% | 182 |
|
|
2015
Q2 | $601K | Hold |
8,109
| – | – | 0.03% | 173 |
|
|
2015
Q1 | $632K | Sell |
8,109
-511
| -6% | -$38.7K | 0.03% | 167 |
|
|
2014
Q4 | $622K | Sell |
8,620
-3,884
| -31% | -$270K | 0.03% | 171 |
|
|
2014
Q3 | $775K | Sell |
12,504
-5,025
| -29% | -$319K | 0.04% | 161 |
|
|
2014
Q2 | $1.12M | Sell |
17,529
-650
| -4% | -$39.5K | 0.05% | 146 |
|
|
2014
Q1 | $1.12M | Sell |
18,179
-1,100
| -6% | -$64.1K | 0.06% | 141 |
|
|
2013
Q4 | $1.11M | Sell |
19,279
-1,050
| -5% | -$59.5K | 0.06% | 134 |
|
|
2013
Q3 | $1.08M | Sell |
20,329
-5,275
| -21% | -$284K | 0.06% | 141 |
|
|
2013
Q2 | $1.32M | Buy |
+25,604
| New | +$1.27M | 0.07% | 121 |
|
Other funds holding MDT
Bartlett & Co's MDT Position: Q4 2023 in Review
Bartlett & Co reduced its Medtronic (MDT) stake by 7.4% in Q4 2023, selling an estimated $71.4K and leaving 11,800 shares worth $984K. The position accounts for 0.02% of the portfolio, ranked #276.
Bartlett & Co first reported a position in MDT in Q2 2013 and has held it in 42 quarters since. The position peaked at $4M in Q3 2019. 2,074 funds tracked by Wall St. Rank hold MDT as of Q4 2023.
- Bartlett & Co held 11,800 shares of Medtronic worth $984K as of Q4 2023.
- Bartlett & Co sold 937 Medtronic shares in Q4 2023, an estimated $71.4K.
- Medtronic made up 0.02% of Bartlett & Co's portfolio in Q4 2023, its #276 holding.
- Bartlett & Co first reported a position in Medtronic in Q2 2013 and has held it in 42 quarters since.
- Bartlett & Co's Medtronic position peaked at $4M in Q3 2019.
- 2,074 funds tracked by Wall St. Rank held Medtronic as of Q4 2023.
Based on Bartlett & Co's 13F filing for Q4 2023, filed 8 Jan 2024.